Equities

Jacobson Pharma Corporation Ltd

Jacobson Pharma Corporation Ltd

Actions
  • Price (HKD)0.590
  • Today's Change-0.01 / -1.67%
  • Shares traded180.00k
  • 1 Year change-7.81%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4121,036479
Total Receivables, Net188301334
Total Inventory318368315
Prepaid expenses------
Other current assets, total465251
Total current assets9641,7571,178
Property, plant & equipment, net1,3011,5021,504
Goodwill, net184451444
Intangibles, net252870859
Long term investments679751702
Note receivable - long term------
Other long term assets954059
Total assets3,4875,3804,756
LIABILITIES
Accounts payable528050
Accrued expenses545852
Notes payable/short-term debt000
Current portion long-term debt/capital leases140344646
Other current liabilities, total12817378
Total current liabilities373656826
Total long term debt6101,255764
Total debt7491,5991,410
Deferred income tax108213207
Minority interest24520467
Other liabilities, total------
Total liabilities1,1152,6442,264
SHAREHOLDERS EQUITY
Common stock201919
Additional paid-in capital1,0381,0001,000
Retained earnings (accumulated deficit)1,1541,6061,515
Treasury stock - common------
Unrealized gain (loss)171138(25)
Other equity, total4.224.286.96
Total equity2,3722,7372,491
Total liabilities & shareholders' equity3,4875,3804,756
Total common shares outstanding1,9801,9081,916
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.